Applications of nanoscale metal-organic frameworks as imaging agents in biology and medicine

被引:99
作者
Duman, Fatma Demir [1 ]
Forgan, Ross S. [1 ]
机构
[1] Univ Glasgow, Sch Chem, WestCHEM, Univ Ave, Glasgow G12 8QQ, Lanark, Scotland
基金
欧洲研究理事会;
关键词
AG2S QUANTUM DOTS; ONE-POT SYNTHESIS; MAGNETIC-RESONANCE; DRUG-DELIVERY; CONTRAST AGENTS; POLYPYRROLE NANOPARTICLES; CONTROLLABLE SYNTHESIS; OXIDE NANOPARTICLES; HIGHLY LUMINESCENT; ENERGY-TRANSFER;
D O I
10.1039/d1tb00358e
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
Nanoscale metal-organic frameworks (NMOFs) are an interesting and unique class of hybrid porous materials constructed by the self-assembly of metal ions/clusters with organic linkers. The high storage capacities, facile synthesis, easy surface functionalization, diverse compositions and excellent biocompatibilities of NMOFs have made them promising agents for theranostic applications. By combination of a large variety of metal ions and organic ligands, and incorporation of desired molecular functionalities including imaging modalities and therapeutic molecules, diverse MOF structures with versatile functionalities can be obtained and utilized in biomedical imaging and drug delivery. In recent years, NMOFs have attracted great interest as imaging agents in optical imaging (OI), magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET) and photoacoustic imaging (PAI). Furthermore, the significant porosity of MOFs allows them to be loaded with multiple imaging agents and therapeutics simultaneously and applied for multimodal imaging and therapy as a single entity. In this review, which is intended as an introduction to the use of MOFs in biomedical imaging for a reader entering the subject, we summarize the up-to-date progress of NMOFs as bioimaging agents, giving (i) a broad perspective of the varying imaging techniques that MOFs can enable, (ii) the different routes to manufacturing functionalised MOF nanoparticles and hybrids, and (iii) the integration of imaging with differing therapeutic techniques. The current challenges and perspectives of NMOFs for their further clinical translation are also highlighted and discussed.
引用
收藏
页码:3423 / 3449
页数:27
相关论文
共 173 条
[1]   A Luminescent Amine-Functionalized Metal-Organic Framework Conjugated with Folic Acid as a Targeted Biocompatible pH-Responsive Nanocarrier for Apoptosis Induction in Breast Cancer Cells [J].
Abazari, Reza ;
Ataei, Farangis ;
Morsali, Ali ;
Slawin, Alexandra M. Z. ;
Carpenter-Warren, Cameron L. .
ACS APPLIED MATERIALS & INTERFACES, 2019, 11 (49) :45442-45454
[2]   Synthesis and applications of metal-organic framework-quantum dot (QD@MOF) composites [J].
Aguilera-Sigalat, Jordi ;
Bradshaw, Darren .
COORDINATION CHEMISTRY REVIEWS, 2016, 307 :267-291
[3]   Preferential accumulation within tumors and in vivo imaging by functionalized luminescent dendrimer lanthanide complexes [J].
Alcala, Marco A. ;
Shade, Chad M. ;
Uh, Hyounsoo ;
Kwan, Shu Ying ;
Bischof, Matthias ;
Thompson, Zachary P. ;
Gogick, Kristy A. ;
Meier, Adam R. ;
Strein, Timothy G. ;
Bartlett, David L. ;
Modzelewski, Ruth A. ;
Lee, Yong J. ;
Petoud, Stephane ;
Brown, Charles K. .
BIOMATERIALS, 2011, 32 (35) :9343-9352
[4]   Luminescent metal-organic frameworks [J].
Allendorf, M. D. ;
Bauer, C. A. ;
Bhakta, R. K. ;
Houk, R. J. T. .
CHEMICAL SOCIETY REVIEWS, 2009, 38 (05) :1330-1352
[5]   Incorporation of biomolecules in Metal-Organic Frameworks for advanced applications [J].
An, Hongde ;
Li, Mingmin ;
Ga, Jia ;
Zhang, Zhenjie ;
Ma, Shengqian ;
Chen, Yao .
COORDINATION CHEMISTRY REVIEWS, 2019, 384 :90-106
[6]   Side Effects of Radiographic Contrast Media [J].
Andreucci, Michele .
BIOMED RESEARCH INTERNATIONAL, 2014, 2014
[7]   Doxil® - The first FDA-approved nano-drug: Lessons learned [J].
Barenholz, Yechezkel .
JOURNAL OF CONTROLLED RELEASE, 2012, 160 (02) :117-134
[8]   PET-Based Personalized Management in Clinical Oncology An Unavoidable Path for the Foreseeable Future [J].
Basu, Sandip ;
Alavi, Abass .
PET CLINICS, 2016, 11 (03) :203-+
[9]  
Beg S, 2017, DRUG DISCOV TODAY, V22, P625, DOI 10.1016/j.drudis.2016.10.001
[10]  
Botchway SW, 2008, P NATL ACAD SCI USA, V105, P16071, DOI 10.1073/pnas.0804071105